Preventing GVHD

Finding Better Ways to Prevent Graft vs Host Disease: Abatacept

STAR is conducting two trials of the drug Abatacept to prevent graft versus host disease in patients at the highest risk of developing this complication.

In Matched Related or Matched Unrelated Bone Marrow Transplantation (BMT) for Sickle Cell Disease.

Bristol-Meyers Squibb
  • Supported by Bristol-Meyers Squibb
  • Opened 2016, anticipated completion 2018
  • Chairs: Monica Bhatia (Columbia University Medical Center) & Sonalia Chaudury (Lurie Children’s Hospital)
Dr. Monica Bhatia
Dr. Monica Bhatia, Co-chair
Dr. Sonalia Chaudury, Co-chair
Dr. Sonalia Chaudury, Co-chair

In Mismatched Unrelated BMT for Sickle Cell Disease and Other Serious Blood Disorders

Thrasher Research Grants
  • Supported by Thrasher Research Foundation
  • Opening October 2018, anticipated completion 2021
  • Chairs: Beth Stenger (Emory/CHOA) & John Horan (Emory/CHOA)
John Horan
Dr. John Horan, Co-chair
Dr. Beth Stenger
Dr. Beth Stenger, Co-chair

Mailing Address

 

STAR
PO Box 96
Great Barrington, MA 01230